France is planning to extend the official expiration dates of widely used medicines in an effort to double their shelf life from two or three years up to five years.
French health authorities will launch scientific studies on 73 frequently prescribed drug references, including paracetamol, to evaluate whether their usable lifespan can be safely prolonged.
The proposed measure aims to tackle massive pharmaceutical waste. Approximately 8,500 tonnes of medicines are discarded every year in France, with a large portion thrown away simply because they have reached their printed expiry date.
However, the relaxation of expiration rules will not apply across the board. Official plans specifically exclude liquid medications and certain other sensitive drug categories from the extension program.
Reducing national medicine disposal
The initiative was reported by French television channel TF1 on its midday news program on August 27, 2026. The report pointed to consumer frustration over existing rules, citing comments that while individuals often feel able to use expired drugs safely, official guidelines currently forbid the practice.
Expiration dates on pharmaceuticals reflect the timeframe during which drug manufacturers guarantee maximum efficacy and chemical stability under proper storage conditions. Paracetamol, a standard over-the-counter pain reliever and fever reducer used by millions, is among the solid-form medications expected to undergo stability testing.
Solid tablets and capsules often maintain active ingredients well beyond their initial two-year or three-year ratings. By extending official shelf life to four or five years for tested formulas, health officials hope to keep safe medications out of incinerators and reduce supply shortages.
Testing and regulatory roll-out
The upcoming research trials will assess the long-term chemical integrity of each of the 73 targeted drug formulations. Regulators will require rigorous evidence of safety and stability before updating official packaging rules nationwide.
If the testing demonstrates that the medicines remain effective, France will formally update expiration guidelines, allowing pharmacies, hospitals, and households to retain and administer non-liquid treatments for up to five years.
